Cantitate/Preț
Produs

Bad Blood: Secrets and Lies in a Silicon Valley Startup: New York Times Bestsellers - Business


Notă:  4.00 · o notă - 1 recenzie 
en Limba Engleză Paperback – 21 mar 2019
'Riveting . . . Compelling . . . A blistering critique of Silicon Valley' Financial Times
'It's no wonder Hollywood is turning this book into a movie. I couldn't put it down.' Bill Gates
The riveting true story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar Silicon Valley biotech startup, by the prize-winning journalist who uncovered the biggest corporate fraud since Enron.
'John Carreyrou's comprehensive take-down of the blood-testing startup Theranos may read like the ultimate dystopian novel for the Silicon Valley age, but unfortunately, it's all true. You will not be able to put this down.' Evening Standard 'Best Tech Books 2018'
'Gripping . . . Just as Theranos was not just a tech company, its story is not just a tech story. It is a parable, with all the usual, delicious ingredients of human folly: greed, pride, vanity, lust, anger' Daily Telegraph
'A tale of corporate fraud and legal browbeating that reads like a crime thriller' Time, 'Non-fiction Book of the Year'
'One of the most gripping reads in years . . . John Carreyrou's book is a testimony to the power of investigative journalism, a beautifully controlled narrative that challenges the gold-rush mentality of Silicon Valley' Lionel Barber, 'Books of the Year', Financial Times
Citește tot Restrânge

Din seria New York Times Bestsellers - Business

Preț: 4009 lei

Preț vechi: 6868 lei
-42%

Puncte Express: 60

Preț estimativ în valută:
768 836$ 656£

Carte indisponibilă temporar

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781509868087
ISBN-10: 1509868089
Pagini: 352
Dimensiuni: 128 x 195 x 27 mm
Greutate: 0.27 kg
Editura: Pan Macmillan
Seria New York Times Bestsellers - Business


Recenzii de la cititorii Books Express


Anonim a dat nota:

This book read like a good thriller!! It had me turning the pages like nothing for quite some time! What makes the whole thing extra scary is the fact that this actually happened. It's really good that there was one journalist and several whistleblowers who weren't afraid to uncover all these lies!

Citește tot Restrânge

Descriere

'I couldn't put down this thriller . . .

the perfect book to read by the fire this winter.' Bill Gates, '5 books I loved in 2018'WINNER OF THE FINANCIAL TIMES/MCKINSEY BUSINESS BOOK OF THE YEAR AWARD 2018The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion.

There was just one problem: The technology didn't work. In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley. Now to be adapted into a film, with Jennifer Lawrence to star.

'Chilling . . .

Reads like a West Coast version of All the President's Men.' New York Times Book Review


Notă biografică

John Carreyrou is a member of the Wall Street Journal's investigative reporting team. He joined the Journal in 1999 and has been based in Brussels, Paris, and New York for the paper. John has covered a number of topics during his career, ranging from Islamist terrorism when he was on assignment in Europe to the pharmaceutical industry and the US healthcare system. His reporting on corruption in the field of spine surgery led to long prison terms for a California hospital owner and a Michigan neurosurgeon. His reporting on Theranos, a blood-testing startup founded by Elizabeth Holmes, was recognized with a George Polk award, and is chronicled in his book Bad Blood: Secrets and Lies in a Silicon Valley Startup.

Born in New York and raised in Paris, he currently resides in Brooklyn with his wife and three children.

Cuprins

A dazzling story of deception in Silicon Valley . . . It is a tale of heroic cupidity on a scale that made the very best and the very brightest look like the very, very foolish . . . You will not be able to put this book down. - Washington Post

Riveting . . . a blistering critique of Silicon Valley, a kind of nonfiction corollary to Dave Eggers's The Circle . . . compelling . . . [Carreyrou's] unmasking of Theranos is a tale of David and Goliath . . . The real heroes, though, are his sources: the young scientists who worked at the company and risked their reputations and careers by voicing their concerns. Were it not for their courage, Theranos might still be testing blood today - David Crow, Financial Times

Carreyrou tells the story virtually to perfection . . . Bad Blood reads like a West Coast version of All the President's Men. - New York Times

Gripping . . . Carreyrou presents the scientific, human, legal and social sides of the story in full . . . He unveils many dark secrets of Theranos that have not previously been laid bare. - Nature

Gripping . . . It is a parable, with all the usual, delicious ingredients of human folly: greed, pride, vanity, lust, anger. Above all, it is an analysis of the phenomenon of hype. - Daily Telegraph

Simply one of the best books about a startup ever. - Forbes

Bad Blood reveals a crucial truth: outside observers must act as the eyes, the ears and, most importantly, the voice of Silicon Valley's blind spot . . . It gambled not with our smart phones, our attention or our democracy, but with people's lives. - Paste

Engaging - The Economist